1. Home
  2. PNTG vs PHAR Comparison

PNTG vs PHAR Comparison

Compare PNTG & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

N/A

Current Price

$34.36

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$15.23

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNTG
PHAR
Founded
2019
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PNTG
PHAR
Price
$34.36
$15.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$36.83
$38.00
AVG Volume (30 Days)
288.6K
19.0K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
20.00
N/A
EPS
0.84
N/A
Revenue
$947,705,000.00
N/A
Revenue This Year
$24.93
$27.92
Revenue Next Year
$7.52
$8.86
P/E Ratio
$40.51
$3,041.22
Revenue Growth
36.31
N/A
52 Week Low
$21.74
$7.50
52 Week High
$35.25
$21.34

Technical Indicators

Market Signals
Indicator
PNTG
PHAR
Relative Strength Index (RSI) 59.00 42.65
Support Level $27.34 $12.98
Resistance Level $35.00 $16.94
Average True Range (ATR) 1.68 0.65
MACD 0.04 0.02
Stochastic Oscillator 82.68 20.00

Price Performance

Historical Comparison
PNTG
PHAR

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: